Beilei Liu
- Molecular Biology
- Oncology top 10%
- Cancer Research top 10%
- Immunology
- Biomedical Engineering
- Co-authors
- Xin‐Yuan GuanLicheng TanHongyu ZhouXiaona FangLanqi GongYu ZhangQian YanLi Fu
- Topics
- RNA modifications and cancer (4 papers)HIV Research and Treatment (3 papers)Epigenetics and DNA Methylation (3 papers)
- Cited by
- Cancer ResearchOncologyImmunology
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Beilei Liu
18 papers receiving 872 citations
Hit Papers
Peers
Comparison fields: 5 of 99
- Molecular Biology 382
- Oncology 291
- Cancer Research 170
- Immunology 160
- Biomedical Engineering 143
Countries citing papers authored by Beilei Liu
This map shows the geographic impact of Beilei Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beilei Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beilei Liu more than expected).
Fields of papers citing papers by Beilei Liu
This network shows the impact of papers produced by Beilei Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beilei Liu. The network helps show where Beilei Liu may publish in the future.
Co-authorship network of co-authors of Beilei Liu
This figure shows the co-authorship network connecting the top 25 collaborators of Beilei Liu. A scholar is included among the top collaborators of Beilei Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beilei Liu. Beilei Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinomabreakdown → | 54 |
| 6 | Exploring treatment options in cancer: tumor treatment strategiesbreakdown → | 412 |
| 7 | 33 | |
| 8 | 8 | |
| 9 | 24 | |
| 10 | 20 | |
| 11 | 27 | |
| 12 | 15 | |
| 13 | 142 | |
| 14 | 6 | |
| 15 | 72 | |
| 16 | 1 | |
| 17 | 55 | |
| 18 | 2 | |
| 19 | 4 | |
| 20 | 3 |
About Beilei Liu
Beilei Liu is a scholar working on Virology, Cancer Research and Immunology, having authored 20 papers that have together received 883 indexed citations. Recurring topics across this work include RNA modifications and cancer (4 papers), HIV Research and Treatment (3 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Cancer Research (170 citations), Oncology (291 citations) and Immunology (160 citations). Beilei Liu has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Xin‐Yuan Guan, Licheng Tan, Hongyu Zhou, Xiaona Fang, Lanqi Gong, Yu Zhang, Qian Yan, Li Fu, Tuxiong Huang and Kaisheng Liu. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.